(STGW) Stagwell - Overview
Stock: Digital Platforms, AI Tools, SaaS Suite, Media Buying, Data Analytics
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 74.9% |
| Relative Tail Risk | -10.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.14 |
| Alpha | -35.21 |
| Character TTM | |
|---|---|
| Beta | 1.155 |
| Beta Downside | 1.111 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.35% |
| CAGR/Max DD | -0.15 |
Description: STGW Stagwell January 14, 2026
Stagwell Inc. (NASDAQ: STGW) is a New-York-based agency network that delivers end-to-end digital transformation services, spanning performance media, data-driven consumer insights, creative communications, and technology development across the U.S., U.K., and other international markets.
The firm builds and licenses proprietary software-including AI-enhanced communication tools, cookie-less data platforms, e-commerce enablement suites, and augmented-reality media solutions-while also offering a full stack of digital production capabilities (websites, mobile apps, back-end systems, and content-management platforms) and omnichannel media planning and buying.
According to its most recent Form 10-K (FY 2023), Stagwell reported revenue of roughly **$1.1 billion**, up **≈12 % YoY**, with SaaS and data-as-a-service contracts now representing **≈45 % of total revenue**, a metric that signals a shift toward higher-margin recurring income. The company posted an operating margin of **~6 %**, reflecting ongoing integration costs but also the scaling of its technology platform.
Key macro drivers for Stagwell’s market include the **steady growth of U.S. digital ad spend** (≈8 % YoY in 2023), accelerated adoption of **cookie-less targeting solutions** due to privacy regulations, and expanding **enterprise investment in AR/VR advertising**, which together underpin demand for the firm’s data-centric and immersive media offerings.
If you want a quantitative benchmark and deeper valuation perspective, a quick look at ValueRay’s analyst notes on STGW’s multiples can provide useful context.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 19.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 1.80 > 1.0 |
| NWC/Revenue: -5.04% < 20% (prev -2.10%; Δ -2.94% < -1%) |
| CFO/TA 0.06 > 3% & CFO 242.8m > Net Income 19.7m |
| Net Debt (1.68b) to EBITDA (361.0m): 4.65 < 3 |
| Current Ratio: 0.89 > 1.5 & < 3 |
| Outstanding Shares: last quarter (259.6m) vs 12m ago 131.4% < -2% |
| Gross Margin: 36.17% > 18% (prev 0.34%; Δ 3584 % > 0.5%) |
| Asset Turnover: 71.73% > 50% (prev 71.20%; Δ 0.53% > 0%) |
| Interest Coverage Ratio: 1.49 > 6 (EBITDA TTM 361.0m / Interest Expense TTM 96.0m) |
Altman Z'' 0.04
| A: -0.03 (Total Current Assets 1.23b - Total Current Liabilities 1.38b) / Total Assets 4.26b |
| B: 0.01 (Retained Earnings 29.5m / Total Assets 4.26b) |
| C: 0.04 (EBIT TTM 143.4m / Avg Total Assets 4.03b) |
| D: 0.00 (Book Value of Equity 7.34m / Total Liabilities 3.48b) |
| Altman-Z'' Score: 0.04 = B |
Beneish M -3.20
| DSRI: 0.85 (Receivables 777.9m/853.8m, Revenue 2.89b/2.70b) |
| GMI: 0.93 (GM 36.17% / 33.59%) |
| AQI: 1.03 (AQ_t 0.65 / AQ_t-1 0.63) |
| SGI: 1.07 (Revenue 2.89b / 2.70b) |
| TATA: -0.05 (NI 19.7m - CFO 242.8m) / TA 4.26b) |
| Beneish M-Score: -3.20 (Cap -4..+1) = AA |
What is the price of STGW shares?
Over the past week, the price has changed by -13.81%, over one month by +4.02%, over three months by -7.83% and over the past year by -18.68%.
Is STGW a buy, sell or hold?
- StrongBuy: 4
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the STGW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 8.3 | 59.3% |
| Analysts Target Price | 8.3 | 59.3% |
| ValueRay Target Price | 4.7 | -9.5% |
STGW Fundamental Data Overview February 03, 2026
P/E Forward = 4.9677
P/S = 0.5379
P/B = 2.0229
Revenue TTM = 2.89b USD
EBIT TTM = 143.4m USD
EBITDA TTM = 361.0m USD
Long Term Debt = 1.53b USD (from longTermDebt, last quarter)
Short Term Debt = 56.8m USD (from shortTermDebt, last quarter)
Debt = 1.81b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.68b USD (from netDebt column, last quarter)
Enterprise Value = 3.23b USD (1.55b + Debt 1.81b - CCE 132.2m)
Interest Coverage Ratio = 1.49 (Ebit TTM 143.4m / Interest Expense TTM 96.0m)
EV/FCF = 15.98x (Enterprise Value 3.23b / FCF TTM 202.3m)
FCF Yield = 6.26% (FCF TTM 202.3m / Enterprise Value 3.23b)
FCF Margin = 7.00% (FCF TTM 202.3m / Revenue TTM 2.89b)
Net Margin = 0.68% (Net Income TTM 19.7m / Revenue TTM 2.89b)
Gross Margin = 36.17% ((Revenue TTM 2.89b - Cost of Revenue TTM 1.84b) / Revenue TTM)
Gross Margin QoQ = 36.62% (prev 35.03%)
Tobins Q-Ratio = 0.76 (Enterprise Value 3.23b / Total Assets 4.26b)
Interest Expense / Debt = 1.39% (Interest Expense 25.2m / Debt 1.81b)
Taxrate = 28.68% (9.55m / 33.3m)
NOPAT = 102.3m (EBIT 143.4m * (1 - 28.68%))
Current Ratio = 0.89 (Total Current Assets 1.23b / Total Current Liabilities 1.38b)
Debt / Equity = 2.35 (Debt 1.81b / totalStockholderEquity, last quarter 770.5m)
Debt / EBITDA = 4.65 (Net Debt 1.68b / EBITDA 361.0m)
Debt / FCF = 8.30 (Net Debt 1.68b / FCF TTM 202.3m)
Total Stockholder Equity = 546.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.49% (Net Income 19.7m / Total Assets 4.26b)
RoE = 3.60% (Net Income TTM 19.7m / Total Stockholder Equity 546.7m)
RoCE = 6.92% (EBIT 143.4m / Capital Employed (Equity 546.7m + L.T.Debt 1.53b))
RoIC = 5.13% (NOPAT 102.3m / Invested Capital 1.99b)
WACC = 5.23% (E(1.55b)/V(3.37b) * Re(10.17%) + D(1.81b)/V(3.37b) * Rd(1.39%) * (1-Tc(0.29)))
Discount Rate = 10.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 48.82%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈166.1m ; Y1≈204.9m ; Y5≈348.9m
Fair Price DCF = 33.65 (EV 10.16b - Net Debt 1.68b = Equity 8.48b / Shares 252.1m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -4.19 | EPS CAGR: -30.84% | SUE: -3.30 | # QB: 0
Revenue Correlation: 59.69 | Revenue CAGR: 5.31% | SUE: 0.23 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.22 | Chg30d=+0.008 | Revisions Net=+2 | Analysts=4
EPS next Year (2026-12-31): EPS=1.06 | Chg30d=+0.053 | Revisions Net=+7 | Growth EPS=+32.5% | Growth Revenue=+11.7%